MN1-transformed Kmt2a SET−/− CMP were able to induce leukemia with the same latency as wild type controls (median survival of 31 days in Kmt2a SET−/− versus 29 days in controls, p = ns) (Fig. 1B). This evidence concerns the gene KMT2A and leukemia.